BioWorld MedTech

Aug. 27, 2018

Senate spending bill for NIH seeks money for drug pricing regulations

The U.S. Senate passed a spending bill that would provide the National Institutes of Health with roughly $39 billion in the coming fiscal year, but the legislation also provides funding for development of drug pricing regulations. Read More

Oxford Biodynamics secures Chinese marketing partner and $12.5M in funding

Researchers use advanced retinal imaging to identify presymptomatic AD patients

Intelligent products are becoming focus of China's future med-tech industry

Head lamp: Rakuten bid with light-activated drug draws $150M in series C

Product briefs

BioWorld MedTech stock report for public med-tech companies

Other news to note

Daily M&A

BioWorld MedTech's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...